Protein detail
KCNN4
Intermediate conductance calcium-activated potassium channel protein 4 (SKCa 4) (SKCa4) (hSK4) (Gardos channel) (IKCa1) (hIK1) (KCa3.1) (Putative Gardos channel) (hKCa4)
Entry name KCNN4 | UniProt ID | EVMP confidence score 0.72 |
Supporting publications (n) 17 | Transmembrane count 6 | Protein classification Disease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsTransportersVoltage-gated ion channels |
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40Basic Information13
Protein Names
Intermediate conductance calcium-activated potassium channel protein 4 (SKCa 4) (SKCa4) (hSK4) (Gardos channel) (IKCa1) (hIK1) (KCa3.1) (Putative Gardos channel) (hKCa4)
Protein Class (7)
Disease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsTransportersVoltage-gated ion channels
Protein Function (6)
- Human disease related genes:Cardiovascular diseases:Hematologic diseases
- Predicted intracellular proteins
- Voltage-gated ion channels:Calcium-Activated Potassium Channels
- Transporters:Transporter channels and pores
- Disease related genes
- FDA approved drug targets:Small molecule drugs
Transmembrane
29..49; Helical; Name=Segment S1; 59..79; Helical; Name=Segment S2; 108..128; Helical; Name=Segment S3; 143..163; Helical; Name=Segment S4; 207..227; Helical; Name=Segment S5; 265..285; Helical; Name=Segment S6
Transmembrane Count
6
Ensembl
Entrez Gene Symbol
Gene Synonym (5)
hIKCa1hKCa4hSK4IKKCa3.1
Gene Description
Potassium calcium-activated channel subfamily N member 4
Chromosome
19
Position
43766533-43780976
Supporting publications (n)
17
EVMP confidence score
0.72
Fluorescence & Localization4
Tissue SpecificbrainCell SpecificAdrenal medulla cellsSingle-Nuclei Brain Specificoligodendrocyte
Function & Pathway8
Protein Function (6)
- Human disease related genes:Cardiovascular diseases:Hematologic diseases
- Predicted intracellular proteins
- Voltage-gated ion channels:Calcium-Activated Potassium Channels
- Transporters:Transporter channels and pores
- Disease related genes
- FDA approved drug targets:Small molecule drugs
Cellular Component (7)
Molecular Function (8)
- GO:0005267 potassium channel activity
- GO:0005515 protein binding
- GO:0005516 calmodulin binding
- GO:0015269 calcium-activated potassium channel activity
- GO:0016286 small conductance calcium-activated potassium channel activity
- GO:0019903 protein phosphatase binding
- GO:0022894 intermediate conductance calcium-activated potassium channel activity
- GO:0042803 protein homodimerization activity
Biological Process (3)
KEGG (4)
Reactome (3)
Canonical Pathways
M187 Pid trkr pathway
Mediation Categories (3)
Clinical-translation mediationFusion and delivery mediationImmune mediation
Relations & Evidence33
Enzyme-Mediated Modification (3)
3 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| KCNN4 | NME2 | P22392 | H | 358 | phosphorylation | PhosphoSite_MIMPMIMPSIGNORProtMapperSIGNOR_ProtMapperPhosphoSite | SIGNOR:18796614SIGNOR:17157250ProtMapper:17157250ProtMapper:18796614 |
| KCNN4 | PHPT1 | Q9NRX4 | H | 358 | dephosphorylation | DEPOD | DEPOD:18796614 |
| KCNN4 | PRKACA | P17612 | S | 334 | phosphorylation | PhosphoSitePhosphoSite_ProtMapperProtMapper |
Ligand-Receptor Signaling (24)
24 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| peripheral | peripheral | OmniPath | No | No | No | No | No |
| plasma_membrane | plasma_membrane | UniProt_location | No | No | No | No | No |
| plasma_membrane | plasma_membrane | OmniPath | No | No | No | No | No |
| transmembrane | transmembrane_predicted | Phobius | No | No | No | No | No |
Page 3 of 3Previous
Regulatory Interaction Network (3)
3 records.
| Source Protein Symbol | Source UniProt ID | Target Protein Symbol | Target UniProt ID | Is Directed | Is Stimulation | Is Inhibition | Database | References |
|---|---|---|---|---|---|---|---|---|
| NDKB | P22392 | KCNN4 | O15554 | Yes | Yes | No | PhosphoSite_MIMPMIMPiPTMnetSIGNORProtMapperSIGNOR_ProtMapper | SIGNOR:18796614SIGNOR:17157250ProtMapper:17157250ProtMapper:18796614 |
| KAPCA | P17612 | KCNN4 | O15554 | Yes | No | Yes | iPTMnetSIGNORProtMapperPhosphoSitePhosphoSite_ProtMapper | PhosphoSite:10617655SIGNOR:25274816 |
| PHP14 | Q9NRX4 | KCNN4 | O15554 | Yes | No | Yes | WangSIGNORDEPOD | SIGNOR:18796614DEPOD:18796614 |
Protein Complex Composition (2)
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationSize Exclusion Chromatography | Mass spectrometry | 37 | 31685984389386743929045923376485265384822805423931508500340717773987372639443544377027153279541429562735285623353873186825471207268019192688484130071318306087003292775933580265273124282732049635856505376863663849095841201090307605383136640736982312403116163983538640091455381366013311476838612515 |
Sequence, Structure & Domains11
Sequences
Length
427
Mass
47,696
Sequence
MGGDLVLGLGALRRRKRLLEQEKSLAGWALVLAGTGIGLMVLHAEMLWFGGCSWALYLFLVKCTISISTFLLLCLIVAFHAKEVQLFMTDNGLRDWRVALTGRQAAQIVLELVVCGLHPAPVRGPPCVQDLGAPLTSPQPWPGFLGQGEALLSLAMLLRLYLVPRAVLLRSGVLLNASYRSIGALNQVRFRHWFVAKLYMNTHPGRLLLGLTLGLWLTTAWVLSVAERQAVNATGHLSDTLWLIPITFLTIGYGDVVPGTMWGKIVCLCTGVMGVCCTALLVAVVARKLEFNKAEKHVHNFMMDIQYTKEMKESAARVLQEAWMFYKHTRRKESHAARRHQRKLLAAINAFRQVRLKHRKLREQVNSMVDISKMHMILYDLQQNLSSSHRALEKQIDTLAGKLDALTELLSTALGPRQLPEPSQQSK
3D Structural Models
Turn
51..56; 172..174; 230..233; 335..337
Helix
12..50; 57..91; 96..99; 104..114; 149..154; 155..161; 162..170; 177..186; 192..202; 204..226; 237..248; 261..287; 293..330; 338..368; 378..413
Beta Strand
254..256
3D Structure
Electron microscopy (4); X-ray crystallography (1)
Domain & Motif Annotations
Domain (CC)
Transmembrane helices S5 and S6 form the ion channel pore, which is surrounded bymembrane embedded helices S1 to S4 (PubMed:29724949). The S4-S5 linker, which contains two distinct helices, undergoes conformational changes upon calmodulin binding to open the channel pore (PubMed:29724949).
Region
286..347; Calmodulin-binding
Protein Families (2)
- Potassium channel KCNN family
- KCa3.1/KCNN4 subfamily
Sequence Similarities
Belongs to the potassium channel KCNN family. KCa3.1/KCNN4 subfamily.
Clinical Relevance6
Disease Involvement (3)
Disease variantFDA approved drug targetsHereditary hemolytic anemia
Related Diseases (4)
Biomarker
Phase 2; Investigative; Discontinued in Phase 2
Drug Targets
FDA approved drug targets
Drugs (3)
Supporting Publications17
| PMID | Title | Abstract |
|---|---|---|
| 38731868 | The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer. | No abstract available |
| 39001700 | Optimized AF4 combined with density cushion ultracentrifugation enables profiling of high-purity human blood extracellular vesicles. | No abstract available |
| 39873726 | Size-Dependent Separation of Extracellular Vesicle Subtypes with Exodisc Enabling Proteomic Analysis in Prostate Cancer. | No abstract available |
| 40091455 | Potential Role of Menstrual Fluid-Derived Small Extracellular Vesicle Proteins in Endometriosis Pathogenesiss. | No abstract available |
| 40098346 | Toward Identification of Markers for Brain-Derived Extracellular Vesicles in Cerebrospinal Fluid: A Large-Scale, Unbiased Analysis Using Proximity Extension Assays. | No abstract available |
| 40545963 | Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple-Negative Breast Cancer. | No abstract available |
| 41315767 | Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma. | No abstract available |
Page 2 of 2Previous